摘要
非酒精性脂肪肝是多种病因导致的慢性疾病,发病率有上升趋势。脂肪肝发生发展与肝内脂肪合成排出动态平衡、激素、胰岛素抵抗等有关,目前还缺少有效治疗药物。综述非酒精性脂肪肝的发病机制、中西药物治疗进展,以期为该领域研究提供借鉴,脂肪肝治疗药物开发提供依据。
Non-alcoholic fatty liver disease is a kind of chronic disease which results from various kinds of factors and its morbidity is increasing. The occurrence and development of non-alcoholic disease is related with the unbalance of synthesis and elimination of fat, hormone and insulin resistance, but until now, there is no effective drug. In this paper, we reviewed the progress of pathogenesis and drug intervention of non-alcoholic fatty disease in order to supply research references for drug development in this area.
出处
《现代生物医学进展》
CAS
2011年第16期3191-3192,3091,共3页
Progress in Modern Biomedicine
关键词
非酒精性脂肪肝
发病机制
药物治疗
胰岛素抵抗
Non-alcoholic fatty liver disease
Pathogenesis mechanism
Drug intervention
Insulin resistance
